$TER

MATZ MARILYN sold $270K of TER

MATZ MARILYN sold 800 shares of TERADYNE, INC (TER) at $337.83 ($0.27M total) on 2026-09-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MATZ MARILYN
Published Sep 16, 2026, 4:19 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 4:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TER
Neutral
high confidence
Mentioned
$TER
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TERNeutralLow
01

Why it matters

The sale represents a routine liquidity event; no immediate strategic shift is indicated.

02

Market read

Insider sale is a standard disclosure with limited trading relevance.

03

What to watch

The 10b5-1 plan may be pre‑scheduled and not reflective of current sentiment.

Relevance 3/10Novelty 4/10Timing: filed 2026-09-16

Background

Form 4 disclosures provide transparent reporting of insider transactions, used by investors to gauge insider confidence.

Company-level read

Ticker impact

$TERNeutralHigh confidence
Context

Director Marilyn Matz sold 800 shares of Teradyne for $270,264 via a 10b5-1 plan, reducing her stake to 14,241 shares.

Expected impact

Minor downward pressure, unlikely to move the stock beyond normal volatility.

Evidence & confidence

Form 4 filings are primary sources; the amount sold is small for a director, so market reaction is expected to be muted.

Market effects

Minimal; Teradyne operates in industrial automation, and a single director sale does not affect sector outlook.

None

None

Counterpoint

If the director is reducing exposure ahead of a negative catalyst, the sale could foreshadow downside.

Key entities

  • Teradyne, Inc.

    Manufacturer of test and industrial automation equipment.

  • Marilyn Matz

    Director of Teradyne.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TERMed

Teradyne Partners With GS Microelectronics On New Semiconductor Test Center — Targets AI, Silicon Photonics And Auto Chips

Teradyne (TER) and GS Microelectronics U.S. (GSME) announced a multi-year partnership to establish a test-and-evaluation center for AI and next-generation chips. The facility, set to open in Q4 2026, will combine GSME's chip design and manufacturing with Teradyne's test systems. Teradyne's Semiconductor Test segment reported record Q2 revenue of $1.12 billion, up 128.1% YoY, driven by AI-related sales. Overall Q2 revenue was $1.33 billion, up 104% YoY. TER shares have risen nearly 90% YTD.

$FORMMedAI 8/10

FormFactor, Entegris, Penguin Solutions, Teradyne, and Marvell Technology Stocks Trade Up, What You Need To Know

Several semiconductor stocks rose after the August jobs report, which showed 162,000 nonfarm payroll jobs added, beating estimates. Despite initial expectations of a rate hike, traders rotated back into the chip sector. FormFactor (FORM) +5.3%, Entegris (ENTG) +5.6%, Penguin Solutions (PENG) +5.1%, Teradyne (TER) +4.8%, and Marvell Technology (MRVL) +6.2%. Marvell reported Q2 revenue of $2.74B, up 36.5% YoY, with strong Data Center demand. Management guided Q3 revenue at $3.15B, but revenue from

$TERMed

Teradyne Stock Plunges 15% in a Month: Should You Buy the Dip?

Teradyne (TER) shares fell 15.4% in a month, underperforming peers and sector. Challenges include customer concentration and muted demand, but AI-driven data center growth and strong Q3 guidance offset this. TER expects $1.20-$1.30B revenue and $1.85-$2.15 EPS for Q3 2026, up significantly YoY. The stock trades at a premium with a forward P/S of 9.35X.